GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » COGS-to-Revenue

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) COGS-to-Revenue : 0.56 (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Aspen Pharmacare Holdings COGS-to-Revenue?

Aspen Pharmacare Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was $635 Mil. Its Revenue for the six months ended in Dec. 2023 was $1,135 Mil.

Aspen Pharmacare Holdings's COGS to Revenue for the six months ended in Dec. 2023 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Aspen Pharmacare Holdings's Gross Margin % for the six months ended in Dec. 2023 was 44.05%.

Aspen Pharmacare Holdings COGS-to-Revenue Historical Data

The historical data trend for Aspen Pharmacare Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings COGS-to-Revenue Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.49 0.53 0.53 0.55

Aspen Pharmacare Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.54 0.53 0.56 0.56

Aspen Pharmacare Holdings COGS-to-Revenue Calculation

Aspen Pharmacare Holdings's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1189.717 / 2171.749
=0.55

Aspen Pharmacare Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=634.848 / 1134.612
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings  (OTCPK:APNHY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Aspen Pharmacare Holdings's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 634.848 / 1134.612
=44.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Aspen Pharmacare Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (OTCPK:APNHY) » Definitions » COGS-to-Revenue
Comparable Companies
JSE:AIP JSE:ASC ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692 NSE:DIVISLAB BOM:500124 SZSE:000963 VTRS NBIX SHSE:600085 SHSE:600196 XPAR:IPN
Traded in Other Exchanges
APN:South Africa
Address
Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Website
https://www.aspenpharma.com
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Headlines

From GuruFocus

Value Idea Contest: Aspen Pharmacare

By Matthew Sipos Matthew Sipos • 03-17-2019

Aspiring for Aspen Pharmacare Holdings Ltd's Dividend: A Comprehensive Analysis

By GuruFocus Research • 09-21-2023